Walsall CCG along with other CCGs across Birmingham and Solihull, Sandwell & West Birmingham, Dudley CCG and Wolverhampton have undertaken phase 3 of the Harmonised Clinical Treatment Policy Project.  This harmonised approach across the footprint of the west midlands is to facilitate consistent, evidence-based policy development for planned patient care.

Between Thursday 5th September 2019 and Friday 11th October 2019, the five Birmingham and Black Country CCGs engaged with clinical colleagues and the public regarding Phase 3a which includes the following 3 DRAFT policies:

Subacromial Pain

To view the DRAFT Policy, click here

To view the DRAFT Patient leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

Image-guided therapeutic intra-articular joint injections with corticosteroids with/without local anaesthetic.

To view the DRAFT Policy, click here

To view the DRAFT Patient leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

Image-guided HIGH VOLUME intra-articular injections (40mls+) of saline with or without corticosteroid and/or local anaesthetic

To view the DRAFT Policy, click here

To view the DRAFT Patient Leaflet, click here

To view the Evidence Summary report, click here

To view the Policy Changes Explained, click here.

Engagement approach and process

As the content of the engagement is clinically complex, it was important that information to allow understanding and therefore meaningful engagement was prepared and shared. For this reason, patient leaflets on each policy were developed to explain the treatment policies. A readers panel was also recruited to consider the draft patient leaflets. The panel made up of 38 members of the public, feedback on the clarity of language and accessibility to content. They were asked the following questions about the leaflets:

  • Was the leaflet easy to read?
  • Did you understand the information?
  • Do you think it needs images?

The engagement process consisted of a questionnaire, targeted outreach engagement with service user-patient groups where possible and general

engagement events. A media release regarding the public and patient engagement was issued to local media to publicise and create awareness around the harmonisation of the polices. It was also promoted through direct emails, social media and information on CCG website information which all provided a link to the online survey.

Engagement activity and feedback summary

What did people tell us?

  • The majority of responses agree that the policies should be harmonised, so the same treatment is available regardless of where you live.
  • Clarification needed on whether existing patients will be affected by the policy changes and whether these changes will affect waiting times to receive treatment.
  • 82% strongly agree or agree that treatments which provide the most benefit to patients should be prioritised.
  • There was an agreement that alternative effective treatment options should be available if current treatments are no longer available.

Engagement and feedback report

To read the full findings from this engagement exercise download the Patient, Public Stakeholder and Clinical Engagement Report.

CCG decision-making

Following the engagement, the recommendation was made to Walsall CCG’s Policy and Commissioning Committee and Governing Body to approve the three clinical treatment policies and proceed to the implementation of the agreed policies from April 2020. Both the committee and Governing Body approved the recommendation. The updated policies will mean that two procedures –arthroscopic shoulder decompression and image-guided high volume intra-articular injections are not routinely commissioned.

To view the reports which were presented to Walsall CCG’s Policy and Commissioning Committee and Governing Body, click the links below.